---
title: "JIR released its 2024 annual performance, with a net profit attributable to the parent company of 30.9754 million yuan, a decrease of 62.65%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233470076.md"
description: "JIR released its 2024 annual report, with operating revenue of 534 million yuan, a year-on-year decrease of 30.58%; net profit attributable to shareholders was 30.9754 million yuan, a year-on-year decline of 62.65%; net profit excluding non-recurring gains and losses was 25.6306 million yuan, a year-on-year decrease of 67.81%. Basic earnings per share were 0.1721 yuan, and it plans to distribute a cash dividend of 0.69 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-03-27T13:35:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233470076.md)
  - [en](https://longbridge.com/en/news/233470076.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233470076.md)
---

# JIR released its 2024 annual performance, with a net profit attributable to the parent company of 30.9754 million yuan, a decrease of 62.65%

According to the Zhitong Finance APP, JIR (300516.SZ) released its annual report for 2024, reporting an operating income of 534 million yuan, a year-on-year decrease of 30.58%. The net profit attributable to shareholders of the listed company was 30.9754 million yuan, a year-on-year decrease of 62.65%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.6306 million yuan, a year-on-year decrease of 67.81%. The basic earnings per share were 0.1721 yuan. In addition, it plans to distribute a cash dividend of 0.69 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [300516.CN](https://longbridge.com/en/quote/300516.CN.md)

## Related News & Research

- [PRESS DIGEST-Canada - August 18](https://longbridge.com/en/news/296230256.md)
- [Quilter says UK housing market remains vulnerable to external shocks despite June price gains](https://longbridge.com/en/news/296335924.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)
- [PCOR: Net income dropped 27% in 1H 2026 as higher costs offset strong sales growth](https://longbridge.com/en/news/296063040.md)
- [Norway PM Støre to open Thor Medical AlphaOne isotope facility Sept. 9](https://longbridge.com/en/news/296304032.md)